NYC ‘Mold Busters’ Project Linked to Fewer ED Asthma Visits
The 'Mold Busters' program in New York City has led to a significant reduction in asthma-related emergency room visits among public housing residents. Following a class action lawsuit, the city improved its response to mold complaints, resulting in faster inspections and remediation. Researchers found that the initiative decreased emergency visits by nearly 2800 annually, demonstrating the positive impact of addressing environmental health factors.
- ▪The 'Mold Busters' program was launched in 2019 to address mold complaints more effectively in NYC public housing.
- ▪Asthma-related emergency room visits dropped by 9 per 1000 residents, translating to 2798 fewer visits annually.
- ▪The study is the first large-scale observational research showing that a city-wide mold intervention can reduce asthma ED visits.
Medscape files mainly under health. We currently carry 231 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Medscape |
| Canonical URL | https://www.medscape.com/viewarticle/mold-remediation-project-public-housing-across-nyc-hailed-2026a1000g18?src=rss |
| Publication time | Mon, 18 May 2026 10:24:40 EDT |
| Retrieval time | 2026-05-18T14:34:56.634Z |
| Last seen | 2026-05-18T14:34:56.634Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | HV9JXYZUL2f5 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
ORLANDO, Fla. — A class action lawsuit filed in 2013 by people with asthma mandated that New York City address mold complaints in a more effective and timely manner. In 2019, the city launched the “Mold Busters” program, and inspection times went from weeks or months down to a mandated 4 days. In addition, the city was required to have a remediation plan in place within 2 weeks. As a result of this wide-scale intervention, there were fewer asthma-related emergency room visits among residents of public housing from 2021 to 2023.“Without this intervention, we expect that there would have been nearly 25% more asthma-related [emergency department] ED visits, so this represents a substantial reduction,” said Nina Flores, PhD, a researcher at Columbia University Mailman School of Public Health…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
